Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer

European Journal of Surgical Oncology

Volumn 38, Issue 2, 2012, Pages 143-149

  Inoue, K ^a   Nakane, Y ^a   Kogire, M ^b   Fujitani, K ^c   Kimura, Y ^d   Imamura, H ^e   Tamura, S ^f   Okano, S ^g   Kwon, A H ^a   Kurokawa, Y ^h   Shimokawa, T ⁱ   Takiuchi, H ^j   Tsujinaka, T ^c   Furukawa, H ^e  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Kishiwada City Hospital   (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

^d OSAKA POLICE HOSPITAL   (Japan)

^e SAKAI MUNICIPAL HOSPITAL   (Japan)

^f KANSAI ROSAI HOSPITAL   (Japan)

^g MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^h OSAKA UNIVERSITY   (Japan)

ⁱ UNIVERSITY OF YAMANASHI   (Japan)

^j OSAKA MEDICAL COLLEGE   (Japan)

more..

Author keywords

Bulky lymph node; Cisplatin; Lymph node dissection; Neoadjuvant chemotherapy; Para aortic lymph node; TS 1

Indexed keywords

CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ANOREXIA; ARTICLE; BRAIN INFARCTION; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; DIARRHEA; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MORBIDITY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADICAL RESECTION; STOMACH ADENOCARCINOMA; SURGICAL MORTALITY; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OXONIC ACID; PREMEDICATION; RISK ASSESSMENT; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TEGAFUR; TREATMENT OUTCOME;

EID: 84855831163     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.11.009     Document Type: Article

References (27)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 2 2001 153 156 (Pubitemid 32911406)
2. T. Matsuda, T. Marugame, K. Kamo Japan Cancer Surveillance Research Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project Jpn J Clin Oncol 39 12 2009 850 858
3. H. Tsukuma, W. Ajiki, A. Ioka Research Group of Population-Based Cancer Registries of Japan Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan Jpn J Clin Oncol 36 9 2006 602 607 (Pubitemid 44593904)
4. K. Inoue, Y. Nakane, and T. Michiura Trends in long-term survival following surgery for gastric cancer: a single institution experience Oncol Rep 11 2 2004 459 464
5. Y. Sakata, A. Ohtu, N. Horikoshi, K. Sugimachi, Y. Mitachi, and T. Taguchi Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegaful-0.4M gimestat- 1M otastat potassium) in advanced gastric cancer patients Eur. J Cancer 34 11 1998 1715 1720 (Pubitemid 28474225)
6. K. Sugimachi, Y. Maehara, and N. Horikoshi An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group Oncology 57 3 1999 202 210 (Pubitemid 29481693)
7. W. Koizumi, S. Tanabe, and K. Saigenji Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer Br J Cancer 89 12 2003 2207 2212 (Pubitemid 38168001)
8. Association, Japanese Gastric Cancer Japanese classification of gastric carcinoma - 2nd English Edition Gastric Cancer 1 1 1998 10 24
9. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 3 2000 205 216
10. S. Takahashi, T. Kinoshita, and M. Konishi Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer Gastric Cancer 4 2001 192 197 (Pubitemid 34201779)
11. W. Koizumi, H. Narahara, and T. Hara S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 3 2008 215 221
12. T. Yoshikawa, K. Omura, and O. Kobayashi A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study) Eur J Surg Oncol 36 6 2010 546 551
13. B. Nakata, A. Tsuji, and Y. Mitachi Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2) Oncology 79 5-6 2010 337 342
14. T. Yoshikawa, A. Tsuburaya, and S. Morita A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS) Jpn J Clin Oncol 40 4 2010 369 372
15. Japan Clinical Oncology Group. Randomized phase III trial of surgery plus neoadjuvant TS-1 and cisplatin compared with surgery alone for type 4 and large type 3 gastric cancer: Japan Clinical Oncology Group Study (JCOG 0501). Clinical Trials. gov NCT00252161. http://clinicaltrials.gov/show/NCT00252161.
16. D. Cunningham, W.H. Allum, and S.P. Stenning MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 335 1 2006 11 20
17. S. Sakuramoto, M. Sasako, and T. Yamaguchi Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 18 2007 1810 1820 (Pubitemid 350044801)
18. D. Takahari, T. Hamaguchi, and K. Yoshimura Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer Cancer Chemother Pharmacol 67 6 2010 1423 1428
19. H. Iwase, M. Shimada, and T. Tsuzuki A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer Oncology 80 1-2 2011 76 83
20. Y. Sato, T. Takayama, and T. Sagawa Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer Cancer Chemother Pharmacol 66 4 2010 721 728
21. H. Narahara, H. Iishi, and H. Imamura Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as firstline treatment for advanced gastric cancer (study GC0301/TOP-002) Gastric Cancer 14 1 2011 72 80
22. Y.J. Bang, E. Van Cutsem, and A. Feyereislova Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 9742 2010 687 697
23. M. Sasako, T. Sano, and S. Yamamoto D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer N Engl J Med 359 5 2008 453 462
24. Y. Yonemura, C.C. Wu, and N. Fukushima Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer Int J Clin Oncol 13 2 2008 132 137 (Pubitemid 351668170)
25. I. Songun, H. Putter, E.M. Kranenbarg, M. Sasako, and C.J. van de Velde Surgical treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial Lancet Oncol 11 5 2010 439 449
26. H.H. Hartgrink, C.J. van de Velde, and H. Putter Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial J Clin Oncol 22 11 2004 2069 2077 (Pubitemid 41095139)
27. T. Sano, M. Sasako, and S. Yamamoto Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group study 9501 J Clin Oncol 22 14 2004 2767 2773 (Pubitemid 41079893)